Join Josh and Ollie as they team up with YBM to launch a British English series, diving into key differences between British and American pronunciation, vocabulary, and expressions. From words like ...

Chronic traumatic encephalopathy has long been discussed as a possible driver of dementia, but proving that link has been ...

Highlights from CTAD 2025 include GLP-1 agonist data, p-tau217 biomarker utility, subcutaneous lecanemab trials, and racial disparities in trial enrollment.

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger-prick blood samples that can be collected at home and mailed to ...

Scientists at Northwestern University used a novel compound to arrest early stages of Alzheimer’s disease in mice — setting the stage, if all goes well, for a groundbreaking treatment in which the ...

Alzheimer’s disease (AD) may be more common than previously thought in some demographic groups, according to the first population-based study to use a blood test to gauge AD-related neuropathological ...

New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance of developing Alzheimer’s disease – and the discovery is pointing to a ...

Could the way we speak — from subtle stutters to repeated words — reveal the earliest signs of Alzheimer’s disease? Researchers and data scientists worldwide think so, and their quest for answers just ...

Alzheimer’s disease is one of humanity’s most formidable foes. It affects 10 percent of people over age 65 and kills more people each year than breast cancer and prostate cancer combined. Its effects ...

Here’s what to know about the other main types and how they affect the brain. By Dana G. Smith Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In ...

Increasing physical activity in midlife or later may reduce the chances of developing dementia by up to 45%, according to a recent study published in JAMA Network Open. Researchers at the Boston ...

Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years of study. The ...